The injectable drug delivery market is a critical segment within the pharmaceutical and healthcare industries, primarily focusing on the administration of medications through injections. This method ...

The global canine arthritis treatment market stands at a valuation of USD 2.50 billion in 2024. Global demand for canine arthritis treatment medications is predicted to rise at a CAGR of 4.20% and ...

The biologic excipients market has become a vital component of the pharmaceutical and biotechnology industries, playing a crucial role in the formulation of biologic drugs. These excipients are ...

The pulmonary arterial hypertension treatment market has witnessed a significant transformation in recent years, driven by advancements in medical research and increasing awareness about rare ...

The whole genome amplification market is anticipated to reach over USD 6.5 million by 2034, with sales projected to reach USD 2.9 million in 2024. The WGA industry is envisioned to register an 8.1% ...

The orthokeratology market is experiencing substantial growth as more individuals seek non-surgical alternatives to correct refractive errors. Orthokeratology, commonly referred to as Ortho-K, ...

The Muscle Stimulation Devices Market is valued at USD 781.9 million USA dollars in 2025. The market to grow through CAGR 3.9% over the forecast years and is expected to reach USD 1,146.6 million by ...

The amniotic membrane market is estimated to stand at USD 1,510.6 million in 2024. The market is forecasted to exceed a valuation of USD 2,279.5 million by 2034, recording a CAGR of 4.2%. Amniotic ...

The global behavioral health market is estimated at USD 127 billion in 2024 and is anticipated to generate revenues of USD 175.7 billion by 2034. The industry is forecast to rise at a CAGR of 3% in ...

GOTHENBURG, SE / ACCESS Newswire / June 4, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, June 4, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company ...

Built on Purpose, Growing with Heart CINCINNATI, OH / ACCESS Newswire / June 3, 2025 / In just one year, AcutePet Urgent Care ...

Sanofi announced today that the U.S. FDA has granted orphan drug designation to rilzabrutinib for the treatment of sickle ...